The CHMP of the EMA has issued a positive opinion for an update of the Summary of Product Characteristics (SmPC) for Pradaxa® (dabigatran etexilate); The CHMP recommends to include data showing that catheter ablation can be conducted in patients o
Myst is the first project to be registered under RERA in Himachal Pradesh
Power2SME Announces Series E Financing investments from existing investors Inventus Capital Partners, Accel, Kalaari Capital and Nandan Nilekani with participation from IFC, a member of the World Bank Group
New global research shows innovators who embrace the promise of Modern Software Development drive greater results with agile processes, attention to security
The 4th edition of BERG Real Estate Awards dwelt on the challenges in promoting access to affordable & Smart Housing in Emerging Markets and honored Developers, Project Consultants, Architects & Interior designers from across India
More than 300 students awarded degrees in various disciplines
The only private Turkish TV channel to broadcast in Africa relies on SES Video to maximize its reach
Global leader in automation control and advanced systems announced its dedicated, physical brand presence in India
Kalagato study ranks ixigo as 2nd biggest mobile travel app in India
Now, all first time Mutual Fund investors can complete their KYC - a one-time mandatory process, in just 2 mins
कंपनी ने आधà¥à¤¨à¤¿à¤•à¤¤à¤® इंजीनियरिंग à¤à¤µà¤‚ ऑपरेशंस सà¥
Using New NikeConnect Technology, Retail Jerseys Will Unlock Exclusive Experiences and Customized Content for Fans' Favorite Teams and Players
Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for Cyltezo® (adalimumab biosimilar) for the treatment of multiple chronic inflammatory diseases; Recommendation based on e